Voloridge Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Voloridge Investment Management's NEO Position: Q2 2026 in Review
Voloridge Investment Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 275,771 shares — an estimated $2.05M sold.
Voloridge Investment Management first reported a position in NEO in Q1 2019 and held it in 21 quarters. The position peaked at $9.53M in Q3 2025. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Voloridge Investment Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
- Voloridge Investment Management sold 275,771 NeoGenomics shares in Q2 2026, an estimated $2.05M.
- Voloridge Investment Management first reported a position in NeoGenomics in Q1 2019 and held it in 21 quarters.
- Voloridge Investment Management's NeoGenomics position peaked at $9.53M in Q3 2025.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.